SENSEX NIFTY

Prabhudas Lilladher

Aug 24, 2016 at 12:39 | Source: CNBC-TV18
While the numbers have been in-line, the company has headroom for better growth, says Surajit Pal, Pharma analyst at Prabhudas Lilladher. Capacity constraints for approved products continue to weigh on Aurobindo.
Aug 23, 2016 at 18:26 | Source: Moneycontrol.com
Prabhudas Lilladher is bullish on HPCL has recommended buy rating on the stock with a target price of Rs 1344 in its research report dated August 22, 2016.
Aug 23, 2016 at 18:25 | Source: Moneycontrol.com
Prabhudas Lilladher has recommended accumulate rating on IGL with a target price of Rs 725 in its research report dated August 22, 2016.
Aug 22, 2016 at 10:27 | Source: CNBC-TV18
Watch the interview of Ajay Bodke of Prabhudas Lilladher with Latha Venkatesh, Anuj Singhal & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Aug 22, 2016 at 09:15 | Source: CNBC-TV18
Watch the interview of Sudarshan Sukhani of s2analytics.com, Ashwani Gujral of ashwanigujral.com, Mitesh Thacker of miteshthacker.com, Prakash Gaba of prakashgaba.com, Ajay Bodke of Prabhudas Lilladher, and Hemant Thukral of Aditya Birla Money with Latha Venkatesh, Anuj Singhal and Sonia Shenoy on CNBC-TV18.
Aug 19, 2016 at 08:45 | Source: Moneycontrol.com
With a bullish stance, Prabhudas Lilladher says that the bank has stayed away from stressed sector lending like steel/power/infra which has helped it to maintain its asset quality at better levels compared to peers despite 60 percent loans in corporate & MSME.
Aug 17, 2016 at 19:22 | Source: CNBC-TV18
Market expert, Jai Bala of Cashthechaos.com believes that Nifty is undergoing a short-term healthy correction.
Aug 17, 2016 at 16:32 | Source: CNBC-TV18
Dilip Bhat of Prabhudas Lilladher is of the view that Jubilant Life Sciences looks good and expects 30-40 percent run up from the current level.
Aug 17, 2016 at 16:31 | Source: CNBC-TV18
Dilip Bhat of Prabhudas Lilladher recommends investing in Dewan Housing Finance with a view of 12-15 months.
Aug 12, 2016 at 11:26 | Source: CNBC-TV18
Surajit Pal of Prabhudas Lilladher talks about Sun Pharma and Glenmark's June quarter earnings.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.